Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
Completed
National Cancer Institute (NCI)
Phase 3
2000-06-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. It is not yet known which regimen of combination chemotherapy is
most effective for lymphoblastic lymphoma.
PURPOSE: This randomized phase III trial is studying different regimens of combination
chemotherapy to compare how well they work in treating children or adolescents with newly
diagnosed stage III or stage IV lymphoblastic lymphoma.
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
Completed
Children's Oncology Group
Phase 3
2000-06-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. It is not yet known which regimen of combination chemotherapy is
most effective for lymphoblastic lymphoma.
PURPOSE: This randomized phase III trial is studying different regimens of combination
chemotherapy to compare how well they work in treating children or adolescents with newly
diagnosed stage III or stage IV lymphoblastic lymphoma.
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
Completed
National Cancer Institute (NCI)
Phase 3
2002-09-01
This randomized phase III trial is studying different chemotherapy regimens given with or
without radiation therapy to compare how well they work in treating children with newly
diagnosed Hodgkin's disease. Drugs used in chemotherapy use different ways to stop cancer
cells from dividing so they stop growing or die. Giving the drugs in different combinations
may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells.
It is not yet known if chemotherapy is more effective with or without additional chemotherapy
and/or radiation therapy in treating Hodgkin's disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
